Treatment sequences and prognostic/predictive factors in metastatic pancreatic ductal adenocarcinoma: univariate and multivariate analyses of a real-world study in Europe

被引：0

作者：

Julien Taieb

Thomas Seufferlein

Michele Reni

Daniel H. Palmer

John A. Bridgewater

Antonio Cubillo

Gerald W. Prager

Alice Vermeire

Fabienne Hédouin-Biville

Zhaoyang Teng

Teresa Macarulla

机构：

[1] Université de Paris,Department of Gastroenterology and Digestive Oncology

[2] Georges Pompidou European Hospital,Department of Internal Medicine I

[3] SIRIC CARPEM,Department of Medicine I

[4] Université Paris-Cité,Vall d´Hebron University Hospital

[5] Hôpital Européen Georges Pompidou,undefined

[6] Hepatogastroenterology and GI Oncology,undefined

[7] University Hospital Ulm,undefined

[8] University Vita E Salute,undefined

[9] IRCCS,undefined

[10] San Raffaele Scientific Institute,undefined

[11] University of Liverpool,undefined

[12] UCL Cancer Institute,undefined

[13] HM CIOCC University Hospital,undefined

[14] Medical University of Vienna,undefined

[15] Servier,undefined

[16] Servier Pharmaceuticals,undefined

[17] Vall d´Hebron Institute of Oncology (VHIO),undefined

[18] IOB Quiron,undefined

来源：

BMC Cancer | / 23卷

关键词：

Pancreatic cancer; Metastatic; Survival; Prognostic factors; Real-world data;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[31] REAL-WORLD TREATMENT PATTERNS AND TREATMENT SEQUENCES IN THE METASTATIC CASTRATION-RESISTANT PROSTATE CANCER SETTINGS ACROSS EUROPE
Castro, E.
Orji, C.
Ribbands, A.
Butcher, J.
Walley, M.
Li, W.
Ghate, S.
VALUE IN HEALTH, 2024, 27 (06) : S227 - S227
[32] The actual 5-year survivors of pancreatic ductal adenocarcinoma based on real-world data
Bengtsson, Axel
Andersson, Roland
Ansari, Daniel
SCIENTIFIC REPORTS, 2020, 10 (01)
[33] Real-world neo-adjuvant with or without adjuvant treatment patterns among pancreatic ductal adenocarcinoma patients in the US
Navaratnam, Prakash
Chase, Monica
Friedman, Howard Steven
Joo, Seongjung
Pishvaian, Michael J.
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[34] The actual 5-year survivors of pancreatic ductal adenocarcinoma based on real-world data
Axel Bengtsson
Roland Andersson
Daniel Ansari
Scientific Reports, 10
[35] Real-world genome profiling in Japanese patients with pancreatic ductal adenocarcinoma focusing on HRD implications
Doi, Toshifumi
Ishikawa, Takeshi
Sakakida, Tomoki
Itani, Junichiro
Sone, Daiki
Morita, Ryuichi
Kataoka, Seita
Miyake, Hayato
Seko, Yuya
Yamaguchi, Kanji
Moriguchi, Michihisa
Sogame, Yoshio
Konishi, Hideyuki
Murashima, Kyoko
Iwasaku, Masahiro
Takayama, Koichi
Itoh, Yoshito
CANCER SCIENCE, 2024, 115 (11) : 3729 - 3739
[36] Treatment outcomes in recurrent versus de novo metastatic pancreatic adenocarcinoma: a real world study
Laura Miotke
Christopher Nevala-Plagemann
Jian Ying
Vaia Florou
Benjamin Haaland
Ignacio Garrido-Laguna
BMC Cancer, 22
[37] Treatment outcomes in recurrent versus de novo metastatic pancreatic adenocarcinoma: a real world study
Miotke, Laura
Nevala-Plagemann, Christopher
Ying, Jian
Florou, Vaia
Haaland, Benjamin
Garrido-Laguna, Ignacio
BMC CANCER, 2022, 22 (01)
[38] SOFT-TISSUE SARCOMATA - SURVIVAL STUDY AND PROGNOSTIC FACTORS USING UNIVARIATE AND MULTIVARIATE ANALYSES
ELJABBOUR, JN
MCLAREN, KM
AKHTAR, SS
KERR, GR
RODGER, A
SMYTH, JF
LEONARD, RCF
JOURNAL OF PATHOLOGY, 1989, 157 (02): : A177 - A177
[39] Real-world outcomes in recurrent versus de novo metastatic pancreatic adenocarcinoma.
Miotke, Laura
Nevala-Plagemann, Christopher Duane
Ying, Jian
Florou, Vaia
Haaland, Benjamin
Garrido-Laguna, Ignacio
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
[40] Real-world overall survival and time to next treatment in patients with metastatic pancreatic ductal adenocarcinoma who received FOLFIRINOX and modified FOLFIRINOX in the first line.
Dennen, Syvart
Boppudi Naga, Sai Sriteja
Cockrum, Paul
Paluri, Ravi Kumar
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 629 - 629

← 1 2 3 4 5 →